Elizabeth Bailey
Co-Founder & Managing Partner @ Foreground Capital
Elizabeth Bailey is a seed investor at Foreground Capital focused on Health Care and Life Science. Elizabeth Bailey is based out of Greater Boston Area and is the Co-Founder and Managing Partner of Foreground Capital. Elizabeth previously worked at RH Capital as a Managing Partner. Elizabeth Bailey attended Harvard Kennedy School.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Elizabeth Bailey invests in
Stages Elizabeth Bailey invests in
Countries Elizabeth Bailey invests in
Investment Focus
Industry
- Health Care 1 (50%)
- Life Science 1 (50%)
- Biotechnology 1 (50%)
- Pharmaceutical 1 (50%)
- Personal Health 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Testmate Health
|
Testmate Health is a medtech startup and award-winning spin-off of University of Geneva (Switzerland). We have developed a smartphone compatible platform test kit that diagnoses any disease with an identifiable DNA or RNA sequence - without the need for a lab, providing results directly at home in minutes. Based on this platform, our firstsolution is the first rapid urine self-test for the four most common sexually transmitted diseases (STD). One million new STDs are diagnosed a day, and yet the best improvements to date still need a lab, with results taking up to 7 days to be ready. Our easy to use all-in-one-kit provides results in minutes, anywhere, at any time, and the result is scannable by a smartphone to enable people to immediately gain access to treatment – if needed. Further test-kits with other diseases are in the pipeline to empower users to skip the waiting room, and take charge of their health from home. | $6M / Seed / May 02, 2024 | |
|
Testmate Health
|
Testmate Health is a medtech startup and award-winning spin-off of University of Geneva (Switzerland). We have developed a smartphone compatible platform test kit that diagnoses any disease with an identifiable DNA or RNA sequence - without the need for a lab, providing results directly at home in minutes. Based on this platform, our firstsolution is the first rapid urine self-test for the four most common sexually transmitted diseases (STD). One million new STDs are diagnosed a day, and yet the best improvements to date still need a lab, with results taking up to 7 days to be ready. Our easy to use all-in-one-kit provides results in minutes, anywhere, at any time, and the result is scannable by a smartphone to enable people to immediately gain access to treatment – if needed. Further test-kits with other diseases are in the pipeline to empower users to skip the waiting room, and take charge of their health from home. | $1.9M / Seed / Oct 21, 2021 |
Co-Investors
About Foreground Capital
Foreground Capital is a venture capital business that invests in early-stage women's health startups to make treatment more accessible, inexpensive, and equitable.
Foreground Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alice Zheng
Co-Founder & Partner
|
|||
|
Elizabeth Bailey
Co-Founder & Managing Partner
|
|||
Stasia Obremskey
Co-Founder & Managing Partner
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Elizabeth Bailey invest in?
Elizabeth Bailey invests primarily in Health Care, Life Science and Biotechnology startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Elizabeth Bailey last invest?
The most recent investment recorded for Elizabeth Bailey closed in May 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
